Question

Difficulty: MediumInfectious Diseases

A 4242-year-old man who recently emigrated from a region with highly endemic tuberculosis is admitted to the hospital due to a 66-week history of worsening productive cough, drenching night sweats, and a 55-kg weight loss. His vital signs show a temperature of 38.2∘C38.2^\circ C (100.8∘F100.8^\circ F). A chest radiograph reveals a distinct cavitary lesion in the apical segment of the right upper lobe.

Arrange the following steps in the most appropriate chronological order for the management of this patient.

  1. 1Transfer the patient to an airborne infection isolation room with negative pressure
  2. 2Obtain multiple sputum specimens for acid-fast bacilli smear and mycobacterial culture
  3. 3Initiate empiric intensive-phase combination therapy with rifampin, isoniazid, pyrazinamide, and ethambutol
  4. 4Narrow treatment to a two-drug continuation phase regimen based on clinical response and susceptibility results

Answer

The correct sequence of management for suspected active pulmonary tuberculosis is: 1) Airborne isolation, 2) Sputum collection for AFB smear and culture, 3) Empiric 4-drug intensive phase therapy, and 4) De-escalation to 2-drug continuation phase therapy.
The standard of care for patients presenting with high clinical and radiographic suspicion for active pulmonary tuberculosis prioritizes infection control, followed by diagnostic sampling, empiric therapy, and eventually targeted therapy.

Step-by-Step Solution

1
Initiate airborne precautions.
The patient is placed in a negative pressure isolation room.
Patients with suspected active pulmonary tuberculosis pose a severe public health and nosocomial risk. Immediate isolation is unequivocally the first step before any diagnostic testing or treatment begins.
2
Collect diagnostic specimens.
Three sputum samples are obtained at least 8 hours apart for AFB smear and mycobacterial culture.
Microbiologic diagnosis and, critically, drug susceptibility testing rely on viable organisms. Administering antibiotics before this step rapidly decreases the diagnostic yield.
3
Start empiric antimycobacterial therapy.
The patient begins the intensive phase with a 4-drug regimen (RIPE: rifampin, isoniazid, pyrazinamide, ethambutol).
Because mycobacterial cultures take weeks to grow, empiric treatment must not be delayed in a highly suspicious presentation once sputum is collected and isolation is secured.
4
De-escalate therapy based on susceptibility data.
Therapy is narrowed to a 2-drug regimen (usually rifampin and isoniazid) for the continuation phase.
Once susceptibilities confirm the isolate is not drug-resistant and the 2-month intensive phase is complete, dropping pyrazinamide and ethambutol reduces cumulative medication toxicity.

Key Concept

Management sequence for suspected active pulmonary tuberculosis
Rate this question